{"ticker": {"uuid": "a136f547-c3e5-4dd1-9456-9d7aa3b76d82", "symbol": "OACC", "name": "Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share", "exchange": "NASDAQ", "country": "US", "sector": "Financial Services", "industry": "Shell Companies"}, "articles": [{"title": "US Financial Stocks Positioned for Higher Rates and Faster Earnings Growth", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-18T07:43:13+00:00", "published_display": "18 Jul 2026 07:43", "sentiment": "positive", "sentiment_pct": 82, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "sector", "tier_label": "Sector context"}, {"title": "Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC) Sees Large Decline in Short Interest", "summary": "Short interest in Oaktree Acquisition Corp. III Life Sciences (NASDAQ: OACC) declined significantly in June, dropping 57.9% to 12,043 shares. The company, a SPAC sponsored by Oaktree Capital Management focusing on the life sciences sector, currently has a \"Sell\" consensus rating ", "url": "https://www.marketbeat.com/instant-alerts/oaktree-acquisition-corp-iii-life-sciences-nasdaqoacc-sees-large-decline-in-short-interest-2026-07-14/", "source_name": "MarketBeat", "published_at": "2026-07-15T08:41:18", "published_display": "15 Jul 2026 08:41", "sentiment": "negative", "sentiment_pct": 38, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC) Trading 0.2% Higher - What's Next?", "summary": "Oaktree Acquisition Corp. III Life Sciences (NASDAQ: OACC) saw its shares increase by 0.2% on Friday, trading at $10.7140 with very light volume. Despite this slight increase, the sentiment for the stock remains weak, with Weiss Ratings reaffirming a \"sell (d)\" rating and MarketB", "url": "https://www.marketbeat.com/instant-alerts/oaktree-acquisition-corp-iii-life-sciences-nasdaqoacc-trading-02-higher-whats-next-2026-07-11/", "source_name": "MarketBeat", "published_at": "2026-07-11T13:11:12", "published_display": "11 Jul 2026 13:11", "sentiment": "negative", "sentiment_pct": 34, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Oaktree Acquisition Corp. III Life Sciences (OACC) Edges Lower Amid Consolidation - Equal Weight ETF", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxQcW9RcmdLZUJVVHhxYVpWUTNwbHBlcnJobjFfeHc3ZVpEaFF6eFhhQVV2czAwaG1YelMtYUdXM2diSnQzLWJKTzM2N0FkcVlocmlyUWh3ZV8za2FMTk9Ldm5zVlJTeVpzbnFWQkdrVTFiQVBlR3RwTkRpZ3hURkVvVjB0ZXpTdmJzNzc4WlROTXlvZE5PVzVKeGFpZTJUUFg4VVhJVzByc0Q1bXUyQWJFRUlzOXpsaXBXSkk0SjJ3?oc=5", "source_name": "dars.gov.et", "published_at": "2026-06-27T07:00:00+00:00", "published_display": "27 Jun 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Oaktree Acquisition Corp. III Life Sciences Unit (OACCU) Holds Steady at $10.73 Amid Limited Trading Activity - Debt Free Companies", "summary": "Oaktree Acquisition Corp. III Life Sciences Unit (OACCU) is trading steadily at $10.73, showing minimal volatility due to its status as a pre-merger SPAC unit awaiting a business combination announcement. The unit's price remains range-bound between support at $10.19 and resistan", "url": "https://newsline.com/first-dry/Oaktree-Acquisition-Corp-III-Life-Sciences-Unit-OACCU-Holds-Steady-at-1073-Amid-Limited-Trading-Activity-28-8579", "source_name": "Newsline", "published_at": "2026-06-10T09:40:34", "published_display": "10 Jun 2026 09:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 96, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Oaktree Acquisition Corp. III Life Sciences (OACC) Holds Steady at $10.65 Amid SPAC Trading Patterns - Gap and Reverse", "summary": "", "url": "https://news.google.com/rss/articles/CBMizgFBVV95cUxNa3FYSzlONzl2QmEtQzRtT1lSYW9LdnotcTJNckVCZlQtSFJsMDBHSXUyWFJ2WkRjYlVhWXB3MWFPYTAtM29iUFgybkF6VGN2NHJvTlI1NVlDSnJPSmdnMGx4bzd0LU5IOEJYVXZJYW02RmRJajhWWnNlNFFuOEdhbk1jZ3Fla1BfM0ZDZXljckpKZDZZcEhOaTVEbW9lamRBcmJXYk9aYTgxOWxieXhGby1jMk9TUGNLSDBuMlhzMnZDOW5nNmF4aVMtTkVnQQ?oc=5", "source_name": "dars.gov.et", "published_at": "2026-06-07T07:00:00+00:00", "published_display": "07 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Oaktree SPAC draws trader attention after 5% filing", "summary": "Oaktree Acquisition Corp. III Life Sciences (OACC), a SPAC, has garnered increased trader attention following a 5% ownership filing by Fort Baker Capital Management LP, which now owns 5.1% of its Class A shares. Goldman Sachs also reported shared voting power over 6.2% of shares.", "url": "https://www.bez-kabli.pl/a-5-filing-just-put-this-oaktree-spac-back-on-traders-radar/", "source_name": "Bez Kabli", "published_at": "2026-05-17T05:25:00", "published_display": "17 May 2026 05:25", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Fort Baker Capital (OACC) reports 5.1% ownership of Oaktree III", "summary": "Fort Baker Capital Management LP has reported a 5.1% beneficial ownership in Oaktree Acquisition Corp. III Life Sciences (OACC) through a Schedule 13G filing. The investment group jointly holds 1,000,000 Class A ordinary shares, indicating shared voting and dispositive power, but", "url": "https://www.stocktitan.net/sec-filings/OACC/schedule-13g-oaktree-acquisition-corp-iii-life-sciences-passive-inves-aa11ee18243a.html", "source_name": "Stock Titan", "published_at": "2026-05-15T18:40:48", "published_display": "15 May 2026 18:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Oaktree Acquisition III Life Sciences (OACC) posts Q1 2026 interest income and flags going concern risk", "summary": "Oaktree Acquisition Corp. III Life Sciences (OACC) reported a net income of $1,394,121 for Q1 2026, primarily from interest earned on its trust account. Despite this, management expressed substantial doubt about the company's ability to continue as a going concern, citing ongoing", "url": "https://www.stocktitan.net/sec-filings/OACC/10-q-oaktree-acquisition-corp-iii-life-sciences-quarterly-earnings-re-6124af095e0a.html", "source_name": "Stock Titan", "published_at": "2026-05-13T21:09:41", "published_display": "13 May 2026 21:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC) Short Interest Down 45.5% in April", "summary": "Short interest in Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC) significantly decreased by 45.5% in April, totaling 27,093 shares as of April 15th. This represents 0.1% of the company's shares and a short-interest ratio of 0.9 days. Analysts maintain a \"Sell\" rating f", "url": "https://www.marketbeat.com/instant-alerts/oaktree-acquisition-corp-iii-life-sciences-nasdaqoacc-short-interest-down-455-in-april-2026-04-27/", "source_name": "MarketBeat", "published_at": "2026-04-27T22:10:15", "published_display": "27 Apr 2026 22:10", "sentiment": "negative", "sentiment_pct": 35, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "JPMorgan Chase & Co. Cuts Holdings in Oaktree Acquisition Corp. III Life Sciences $OACC", "summary": "JPMorgan Chase & Co. significantly reduced its stake in Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC) by 62.5% in the third quarter, selling 124,959 shares and retaining 74,817 shares valued at $783,000. While JPMorgan Chase decreased its holdings, other institutional", "url": "https://www.marketbeat.com/instant-alerts/filing-jpmorgan-chase-co-cuts-holdings-in-oaktree-acquisition-corp-iii-life-sciences-oacc-2026-04-12/", "source_name": "MarketBeat", "published_at": "2026-04-12T09:10:15", "published_display": "12 Apr 2026 09:10", "sentiment": "negative", "sentiment_pct": 40, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Berkley W R Corp Buys 124,315 Shares of Oaktree Acquisition Corp. III Life Sciences $OACC", "summary": "Berkley W R Corp significantly increased its stake in Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC) by 125.2%, purchasing an additional 124,315 shares to own a total of 223,645 shares valued at $2.35 million. Other institutional investors like UBS Group AG also booste", "url": "https://www.marketbeat.com/instant-alerts/filing-berkley-w-r-corp-buys-124315-shares-of-oaktree-acquisition-corp-iii-life-sciences-oacc-2026-03-15/", "source_name": "MarketBeat", "published_at": "2026-03-15T09:10:33", "published_display": "15 Mar 2026 09:10", "sentiment": "positive", "sentiment_pct": 65, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Radcliffe Capital Management L.P. Has $2.37 Million Holdings in Oaktree Acquisition Corp. III Life Sciences $OACC", "summary": "Radcliffe Capital Management L.P. significantly increased its stake in Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC) by 175.5% in the third quarter, now holding 225,662 shares valued at approximately $2.37 million. Other major investors like Goldman Sachs, Moore Capit", "url": "https://www.marketbeat.com/instant-alerts/filing-radcliffe-capital-management-lp-has-237-million-holdings-in-oaktree-acquisition-corp-iii-life-sciences-oacc-2026-03-14/", "source_name": "MarketBeat", "published_at": "2026-03-14T10:52:27", "published_display": "14 Mar 2026 10:52", "sentiment": "positive", "sentiment_pct": 65, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Oaktree Acquisition Corp. III Life Sciences (OACCW) Competitors", "summary": "This article provides a detailed comparison of Oaktree Acquisition Corp. III Life Sciences (OACCW) with numerous competitors within the Financial Services sector, specifically focusing on Shell Companies. It lists several peer companies along with key financial metrics such as ma", "url": "https://meyka.com/stock/OACCW/peers/", "source_name": "Meyka", "published_at": "2026-03-12T08:39:39", "published_display": "12 Mar 2026 08:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OACC Stock Price and Chart \u2014 NASDAQ:OACC", "summary": "This article provides comprehensive financial data, charts, and technical analysis for Oaktree Acquisition Corp. III Life Sciences (OACC) stock on NASDAQ. It details key statistics, company information, performance metrics, and frequently asked questions regarding its stock price", "url": "https://www.tradingview.com/symbols/NASDAQ-OACC/", "source_name": "TradingView", "published_at": "2026-03-04T02:52:53", "published_display": "04 Mar 2026 02:52", "sentiment": "positive", "sentiment_pct": 59, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Short Interest in Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC) Grows By 24.4%", "summary": "Short interest in Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC) rose by 24.4% to 50,180 shares as of February 13th, representing 0.2% of the stock's shares and a short-interest ratio of 3.2 days. Several institutional investors, including Empyrean Capital Partners and", "url": "https://www.marketbeat.com/instant-alerts/short-interest-in-oaktree-acquisition-corp-iii-life-sciences-nasdaqoacc-grows-by-244-2026-03-03/", "source_name": "MarketBeat", "published_at": "2026-03-03T15:52:53", "published_display": "03 Mar 2026 15:52", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Short Interest in Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC) Declines By 21.5%", "summary": "Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC) experienced a 21.5% decline in short interest during January, falling to 40,324 shares by January 30th. Institutional investors increased their exposure to OACC, with firms like Millennium Management, Goldman Sachs, Albert", "url": "https://www.marketbeat.com/instant-alerts/short-interest-in-oaktree-acquisition-corp-iii-life-sciences-nasdaqoacc-declines-by-215-2026-02-15/", "source_name": "MarketBeat", "published_at": "2026-02-15T19:27:53", "published_display": "15 Feb 2026 19:27", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC) Trading Up 0.4% - What's Next?", "summary": "Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC) saw its stock rise by 0.4% during Friday's trading, with a significant increase in trading volume. Despite this uptick, the stock currently holds a consensus \"Sell\" rating from analysts, including a reiteration of \"Sell (d", "url": "https://www.marketbeat.com/instant-alerts/oaktree-acquisition-corp-iii-life-sciences-nasdaqoacc-trading-up-04-whats-next-2026-01-31/", "source_name": "MarketBeat", "published_at": "2026-01-31T08:00:33", "published_display": "31 Jan 2026 08:00", "sentiment": "negative", "sentiment_pct": 40, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Oaktree Acquisition Corp. III Life Sciences SEC 10-Q Report", "summary": "Oaktree Acquisition Corp. III Life Sciences (OACC), a blank check company, filed its Form 10-Q report for the quarter ended September 30, 2025. The report details a net income of $1.97 million for the quarter and $5.50 million for the nine months, primarily from interest earned o", "url": "https://www.tradingview.com/news/tradingview:c5b09d8eeac51:0-oaktree-acquisition-corp-iii-life-sciences-sec-10-q-report/", "source_name": "TradingView", "published_at": "2025-11-13T08:40:25", "published_display": "13 Nov 2025 08:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Oaktree Acquisition Corp. III Appoints New CFO", "summary": "Oaktree Acquisition Corp. III Life Sciences Class A (OACC) has appointed George A. Martinez as its new Chief Financial Officer, succeeding Thomas Sweeney who resigned on October 29, 2025. Martinez, a Senior Vice President at Oaktree Capital Management and a Certified Public Accou", "url": "https://www.theglobeandmail.com/investing/markets/stocks/OACC/pressreleases/35809691/oaktree-acquisition-corp-iii-appoints-new-cfo/", "source_name": "The Globe and Mail", "published_at": "2025-10-30T10:10:07", "published_display": "30 Oct 2025 10:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Oaktree Acquisition Corp. III Life Sciences appoints David A. Berry as director By Investing.com - Investing.com Australia", "summary": "Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC) announced the appointment of David A. Berry, MD, PhD, as an independent director. Dr. Berry, co-founder of Averin Capital and former partner at Flagship Pioneering, brings extensive experience from the life sciences sector", "url": "https://m.au.investing.com/news/sec-filings/oaktree-acquisition-corp-iii-life-sciences-appoints-david-a-berry-as-director-93CH-4068354?ampMode=1", "source_name": "Investing.com Australia", "published_at": "2025-10-18T12:04:26", "published_display": "18 Oct 2025 12:04", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Oaktree Acquisition Corp. III Life Sciences appoints David A. Berry as director By Investing.com - Investing.com South Africa", "summary": "This article reports on the appointment of David A. Berry as a director for Oaktree Acquisition Corp. III Life Sciences. The article content itself is unfortunately missing due to an application error on the source website.", "url": "https://za.investing.com/news/sec-filings/oaktree-acquisition-corp-iii-life-sciences-appoints-david-a-berry-as-director-93CH-3927179", "source_name": "Investing.com South Africa", "published_at": "2025-10-18T00:16:11", "published_display": "18 Oct 2025 00:16", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Oaktree Acquisition Corp. III Life Sciences appoints David A. Berry as director - Investing.com", "summary": "Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC) has appointed David A. Berry, MD, PhD, as an independent director, who will also serve on the audit, nominating, and compensation committees. Dr. Berry brings extensive experience from Averin Capital and Flagship Pioneerin", "url": "https://m.investing.com/news/sec-filings/oaktree-acquisition-corp-iii-life-sciences-appoints-david-a-berry-as-director-93CH-4295688?ampMode=1", "source_name": "Investing.com", "published_at": "2025-10-17T21:34:00", "published_display": "17 Oct 2025 21:34", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Oaktree Acquisition Corp. III Life Sciences appoints David A. Berry as director", "summary": "Oaktree Acquisition Corp. III Life Sciences has appointed Dr. David A. Berry as an independent director, who will also serve on the audit, nominating, and compensation committees. Dr. Berry brings extensive experience from Averin Capital and Flagship Pioneering, along with his me", "url": "https://www.investing.com/news/sec-filings/oaktree-acquisition-corp-iii-life-sciences-appoints-david-a-berry-as-director-4295688", "source_name": "Investing.com", "published_at": "2025-10-17T17:34:00", "published_display": "17 Oct 2025 17:34", "sentiment": "positive", "sentiment_pct": 71, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Oaktree Acquisition III (OACC) Stock Price, News & Analysis", "summary": "Oaktree Acquisition Corp. III Life Sciences (OACC) is a blank check company operating in the Financial Services sector, with its securities listed on Nasdaq. The article details its business structure, including units, Class A ordinary shares, and redeemable warrants, and highlig", "url": "https://www.stocktitan.net/overview/OACC/", "source_name": "Stock Titan", "published_at": "2025-04-26T05:09:04", "published_display": "26 Apr 2025 05:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Oaktree Acquisition Corp. III Life Sciences (OACC) Stock Price, News & Analysis", "summary": "Oaktree Acquisition Corp. III Life Sciences (OACC) is a SPAC focused on business combinations within the life sciences sector, sponsored by Oaktree Capital Management. As of February 14, 2025, OACC shares are trading at $10.70, up 1.1% since January 1st, 2026. The company is acti", "url": "https://www.marketbeat.com/stocks/NASDAQ/OACC/", "source_name": "MarketBeat", "published_at": "2025-02-14T02:52:03", "published_display": "14 Feb 2025 02:52", "sentiment": "positive", "sentiment_pct": 65, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "The Roundup: Top Takeaways from Oaktree\u2019s Quarterly Letters - December 2023 Edition", "summary": "Oaktree Capital Management's December 2023 \"Roundup\" synthesizes insights from its experts on the 2023 credit markets and future opportunities. Key takeaways include Howard Marks's perspective on interest rates and inflation, suggesting a \"new normal\" for investment strategies. O", "url": "https://www.oaktreecapital.com/insights/insight-commentary/market-commentary/the-roundup-top-takeaways-from-oaktrees-quarterly-letters-december-2023-edition", "source_name": "Oaktree Capital Management", "published_at": "2023-12-14T13:09:11", "published_display": "14 Dec 2023 13:09", "sentiment": "positive", "sentiment_pct": 72, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OACC.U IPO News - Oaktree Capital's SPAC Oaktree Acquisition III withdraws $225 million IPO", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxOQm9pWWFZckVBU0JVYW9KMWlMR3RMZ3lINDYyalVUM0sxdTQzcVRpMGV0NW5WQ1NyTGFQeEFkcWMxNlRNXzZaR3ZBMGRSUXRkbWo3WDdNZ01zZnZDaU5ScFl5UkEydUVTUDZjb3FEWUxoS0c5Y25STDBXRTd5VkJ0M2IwN3FwMWNQS0VjV3pFQTlsNHYtbkRCLXNFY2lpQUphT3lOcm5sRmR6NkJKWkRQc2dNWW5KZGdBbU9SenNmQV93WEUyUGVWaw?oc=5", "source_name": "renaissancecapital.com", "published_at": "2023-02-06T08:00:00+00:00", "published_display": "06 Feb 2023 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Alex Rodriguez and Jennifer Lopez\u2019s Hims & Hers Investment Pays With Oaktree SPAC", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPNTFMcXRINzYwVDlNVEpNNW9henoxd1NTcUdSRDhrZlVqWVAtREVmTTEyUzkxSFVRWGd5eFJGUjJMYTdKN1RmODN5ZVdMN0ltcWpobFY0VjFxWHVtVjdwX05pT1EzT1dsQVFvTURFX09pLWlwVUJhMFpkZG5GUHFDVUtpMnhURHg4ZUhsd1hPa1pWOWRnRUlINnhNanB0UQ?oc=5", "source_name": "Variety", "published_at": "2021-01-12T08:00:00+00:00", "published_display": "12 Jan 2021 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hers, a Multi-Specialty Telehealth Platform, to Become Publicly-Traded via Merger with Oaktree Acquisition Corp.", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiwJBVV95cUxPY1dUNl9EWnkyT3d1UVZzTHdOZHpOUURGN202U1JhZ1FqTDcwalA1X0xpWGJFckJmUVRmNFBUOWw2SnVEazltaTQxVzVfT04tRGtjeDdVOXZkaWh1cDhiN3NaWHpVeWhaWjBpTFIyVHcwZ3pmVmJPeHd5bFJDbVRsLWxjem13dUdaTlI4QjRLMHFuUWpKUy1LNW51Z2wzN1BMYzZFOVhuSGoybDl4Y3FJZHNIcVZOTWZLeFFPSEhGWExRdmdfUzItMjNHbjB4TjJWNWNzSXhvSWNsZmZVQU1MRTE0WGZ1MmVBVGNXcy04d0hPb3ZETTVzZjdJOXhIb0hzRDJKN1RqbkRQZms?oc=5", "source_name": "HIMS Investor Relations", "published_at": "2020-10-01T07:00:00+00:00", "published_display": "01 Oct 2020 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 96, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Oaktree Acquisition (OAC) Stock Price, News & Analysis $OAC", "summary": "This page provides detailed stock analysis, news, and key financial statistics for Oaktree Acquisition (OAC). It includes real-time data like stock price range, volume, and market capitalization, along with news headlines and information on what other stocks OAC shareholders own.", "url": "https://www.marketbeat.com/stocks/NYSE/OAC/", "source_name": "MarketBeat", "published_at": "2020-09-21T14:09:34", "published_display": "21 Sep 2020 14:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Brookfield Buys Majority Stake in Oaktree Capital for Reported $4.7B", "summary": "Brookfield Asset Management is acquiring a majority stake in Oaktree Capital Management for an estimated $4.7 billion. This strategic move strengthens Brookfield's alternative asset management business and expands its reach, while Oaktree Capital gains access to Brookfield's glob", "url": "https://www.globest.com/2019/03/14/brookfield-buys-majority-stake-in-oaktree-capital-for-reported-4-7b/", "source_name": "Globest", "published_at": "2019-03-14T07:44:00", "published_display": "14 Mar 2019 07:44", "sentiment": "positive", "sentiment_pct": 66, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC) Sees Large Decline in Short Interest", "summary": "Short interest in Oaktree Acquisition Corp. III Life Sciences (NASDAQ: OACC) declined significantly in June, dropping 57.9% to 12,043 shares. The company, a SPAC sponsored by Oaktree Capital Management focusing on the life sciences sector, currently has a \"Sell\" consensus rating ", "url": "https://www.marketbeat.com/instant-alerts/oaktree-acquisition-corp-iii-life-sciences-nasdaqoacc-sees-large-decline-in-short-interest-2026-07-14/", "source_name": "MarketBeat", "published_at": "2026-07-15T08:41:18", "published_display": "15 Jul 2026 08:41", "sentiment": "negative", "sentiment_pct": 38, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC) Trading 0.2% Higher - What's Next?", "summary": "Oaktree Acquisition Corp. III Life Sciences (NASDAQ: OACC) saw its shares increase by 0.2% on Friday, trading at $10.7140 with very light volume. Despite this slight increase, the sentiment for the stock remains weak, with Weiss Ratings reaffirming a \"sell (d)\" rating and MarketB", "url": "https://www.marketbeat.com/instant-alerts/oaktree-acquisition-corp-iii-life-sciences-nasdaqoacc-trading-02-higher-whats-next-2026-07-11/", "source_name": "MarketBeat", "published_at": "2026-07-11T13:11:12", "published_display": "11 Jul 2026 13:11", "sentiment": "negative", "sentiment_pct": 34, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Oaktree Acquisition Corp. III Life Sciences (OACC) Edges Lower Amid Consolidation - Equal Weight ETF", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxQcW9RcmdLZUJVVHhxYVpWUTNwbHBlcnJobjFfeHc3ZVpEaFF6eFhhQVV2czAwaG1YelMtYUdXM2diSnQzLWJKTzM2N0FkcVlocmlyUWh3ZV8za2FMTk9Ldm5zVlJTeVpzbnFWQkdrVTFiQVBlR3RwTkRpZ3hURkVvVjB0ZXpTdmJzNzc4WlROTXlvZE5PVzVKeGFpZTJUUFg4VVhJVzByc0Q1bXUyQWJFRUlzOXpsaXBXSkk0SjJ3?oc=5", "source_name": "dars.gov.et", "published_at": "2026-06-27T07:00:00+00:00", "published_display": "27 Jun 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Oaktree Acquisition Corp. III Life Sciences Unit (OACCU) Holds Steady at $10.73 Amid Limited Trading Activity - Debt Free Companies", "summary": "Oaktree Acquisition Corp. III Life Sciences Unit (OACCU) is trading steadily at $10.73, showing minimal volatility due to its status as a pre-merger SPAC unit awaiting a business combination announcement. The unit's price remains range-bound between support at $10.19 and resistan", "url": "https://newsline.com/first-dry/Oaktree-Acquisition-Corp-III-Life-Sciences-Unit-OACCU-Holds-Steady-at-1073-Amid-Limited-Trading-Activity-28-8579", "source_name": "Newsline", "published_at": "2026-06-10T09:40:34", "published_display": "10 Jun 2026 09:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 96, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Oaktree Acquisition Corp. III Life Sciences (OACC) Holds Steady at $10.65 Amid SPAC Trading Patterns - Gap and Reverse", "summary": "", "url": "https://news.google.com/rss/articles/CBMizgFBVV95cUxNa3FYSzlONzl2QmEtQzRtT1lSYW9LdnotcTJNckVCZlQtSFJsMDBHSXUyWFJ2WkRjYlVhWXB3MWFPYTAtM29iUFgybkF6VGN2NHJvTlI1NVlDSnJPSmdnMGx4bzd0LU5IOEJYVXZJYW02RmRJajhWWnNlNFFuOEdhbk1jZ3Fla1BfM0ZDZXljckpKZDZZcEhOaTVEbW9lamRBcmJXYk9aYTgxOWxieXhGby1jMk9TUGNLSDBuMlhzMnZDOW5nNmF4aVMtTkVnQQ?oc=5", "source_name": "dars.gov.et", "published_at": "2026-06-07T07:00:00+00:00", "published_display": "07 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Oaktree SPAC draws trader attention after 5% filing", "summary": "Oaktree Acquisition Corp. III Life Sciences (OACC), a SPAC, has garnered increased trader attention following a 5% ownership filing by Fort Baker Capital Management LP, which now owns 5.1% of its Class A shares. Goldman Sachs also reported shared voting power over 6.2% of shares.", "url": "https://www.bez-kabli.pl/a-5-filing-just-put-this-oaktree-spac-back-on-traders-radar/", "source_name": "Bez Kabli", "published_at": "2026-05-17T05:25:00", "published_display": "17 May 2026 05:25", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Fort Baker Capital (OACC) reports 5.1% ownership of Oaktree III", "summary": "Fort Baker Capital Management LP has reported a 5.1% beneficial ownership in Oaktree Acquisition Corp. III Life Sciences (OACC) through a Schedule 13G filing. The investment group jointly holds 1,000,000 Class A ordinary shares, indicating shared voting and dispositive power, but", "url": "https://www.stocktitan.net/sec-filings/OACC/schedule-13g-oaktree-acquisition-corp-iii-life-sciences-passive-inves-aa11ee18243a.html", "source_name": "Stock Titan", "published_at": "2026-05-15T18:40:48", "published_display": "15 May 2026 18:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Oaktree Acquisition III Life Sciences (OACC) posts Q1 2026 interest income and flags going concern risk", "summary": "Oaktree Acquisition Corp. III Life Sciences (OACC) reported a net income of $1,394,121 for Q1 2026, primarily from interest earned on its trust account. Despite this, management expressed substantial doubt about the company's ability to continue as a going concern, citing ongoing", "url": "https://www.stocktitan.net/sec-filings/OACC/10-q-oaktree-acquisition-corp-iii-life-sciences-quarterly-earnings-re-6124af095e0a.html", "source_name": "Stock Titan", "published_at": "2026-05-13T21:09:41", "published_display": "13 May 2026 21:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC) Short Interest Down 45.5% in April", "summary": "Short interest in Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC) significantly decreased by 45.5% in April, totaling 27,093 shares as of April 15th. This represents 0.1% of the company's shares and a short-interest ratio of 0.9 days. Analysts maintain a \"Sell\" rating f", "url": "https://www.marketbeat.com/instant-alerts/oaktree-acquisition-corp-iii-life-sciences-nasdaqoacc-short-interest-down-455-in-april-2026-04-27/", "source_name": "MarketBeat", "published_at": "2026-04-27T22:10:15", "published_display": "27 Apr 2026 22:10", "sentiment": "negative", "sentiment_pct": 35, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "JPMorgan Chase & Co. Cuts Holdings in Oaktree Acquisition Corp. III Life Sciences $OACC", "summary": "JPMorgan Chase & Co. significantly reduced its stake in Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC) by 62.5% in the third quarter, selling 124,959 shares and retaining 74,817 shares valued at $783,000. While JPMorgan Chase decreased its holdings, other institutional", "url": "https://www.marketbeat.com/instant-alerts/filing-jpmorgan-chase-co-cuts-holdings-in-oaktree-acquisition-corp-iii-life-sciences-oacc-2026-04-12/", "source_name": "MarketBeat", "published_at": "2026-04-12T09:10:15", "published_display": "12 Apr 2026 09:10", "sentiment": "negative", "sentiment_pct": 40, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Berkley W R Corp Buys 124,315 Shares of Oaktree Acquisition Corp. III Life Sciences $OACC", "summary": "Berkley W R Corp significantly increased its stake in Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC) by 125.2%, purchasing an additional 124,315 shares to own a total of 223,645 shares valued at $2.35 million. Other institutional investors like UBS Group AG also booste", "url": "https://www.marketbeat.com/instant-alerts/filing-berkley-w-r-corp-buys-124315-shares-of-oaktree-acquisition-corp-iii-life-sciences-oacc-2026-03-15/", "source_name": "MarketBeat", "published_at": "2026-03-15T09:10:33", "published_display": "15 Mar 2026 09:10", "sentiment": "positive", "sentiment_pct": 65, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Radcliffe Capital Management L.P. Has $2.37 Million Holdings in Oaktree Acquisition Corp. III Life Sciences $OACC", "summary": "Radcliffe Capital Management L.P. significantly increased its stake in Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC) by 175.5% in the third quarter, now holding 225,662 shares valued at approximately $2.37 million. Other major investors like Goldman Sachs, Moore Capit", "url": "https://www.marketbeat.com/instant-alerts/filing-radcliffe-capital-management-lp-has-237-million-holdings-in-oaktree-acquisition-corp-iii-life-sciences-oacc-2026-03-14/", "source_name": "MarketBeat", "published_at": "2026-03-14T10:52:27", "published_display": "14 Mar 2026 10:52", "sentiment": "positive", "sentiment_pct": 65, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Oaktree Acquisition Corp. III Life Sciences (OACCW) Competitors", "summary": "This article provides a detailed comparison of Oaktree Acquisition Corp. III Life Sciences (OACCW) with numerous competitors within the Financial Services sector, specifically focusing on Shell Companies. It lists several peer companies along with key financial metrics such as ma", "url": "https://meyka.com/stock/OACCW/peers/", "source_name": "Meyka", "published_at": "2026-03-12T08:39:39", "published_display": "12 Mar 2026 08:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OACC Stock Price and Chart \u2014 NASDAQ:OACC", "summary": "This article provides comprehensive financial data, charts, and technical analysis for Oaktree Acquisition Corp. III Life Sciences (OACC) stock on NASDAQ. It details key statistics, company information, performance metrics, and frequently asked questions regarding its stock price", "url": "https://www.tradingview.com/symbols/NASDAQ-OACC/", "source_name": "TradingView", "published_at": "2026-03-04T02:52:53", "published_display": "04 Mar 2026 02:52", "sentiment": "positive", "sentiment_pct": 59, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Short Interest in Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC) Grows By 24.4%", "summary": "Short interest in Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC) rose by 24.4% to 50,180 shares as of February 13th, representing 0.2% of the stock's shares and a short-interest ratio of 3.2 days. Several institutional investors, including Empyrean Capital Partners and", "url": "https://www.marketbeat.com/instant-alerts/short-interest-in-oaktree-acquisition-corp-iii-life-sciences-nasdaqoacc-grows-by-244-2026-03-03/", "source_name": "MarketBeat", "published_at": "2026-03-03T15:52:53", "published_display": "03 Mar 2026 15:52", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Short Interest in Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC) Declines By 21.5%", "summary": "Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC) experienced a 21.5% decline in short interest during January, falling to 40,324 shares by January 30th. Institutional investors increased their exposure to OACC, with firms like Millennium Management, Goldman Sachs, Albert", "url": "https://www.marketbeat.com/instant-alerts/short-interest-in-oaktree-acquisition-corp-iii-life-sciences-nasdaqoacc-declines-by-215-2026-02-15/", "source_name": "MarketBeat", "published_at": "2026-02-15T19:27:53", "published_display": "15 Feb 2026 19:27", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC) Trading Up 0.4% - What's Next?", "summary": "Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC) saw its stock rise by 0.4% during Friday's trading, with a significant increase in trading volume. Despite this uptick, the stock currently holds a consensus \"Sell\" rating from analysts, including a reiteration of \"Sell (d", "url": "https://www.marketbeat.com/instant-alerts/oaktree-acquisition-corp-iii-life-sciences-nasdaqoacc-trading-up-04-whats-next-2026-01-31/", "source_name": "MarketBeat", "published_at": "2026-01-31T08:00:33", "published_display": "31 Jan 2026 08:00", "sentiment": "negative", "sentiment_pct": 40, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Oaktree Acquisition Corp. III Life Sciences SEC 10-Q Report", "summary": "Oaktree Acquisition Corp. III Life Sciences (OACC), a blank check company, filed its Form 10-Q report for the quarter ended September 30, 2025. The report details a net income of $1.97 million for the quarter and $5.50 million for the nine months, primarily from interest earned o", "url": "https://www.tradingview.com/news/tradingview:c5b09d8eeac51:0-oaktree-acquisition-corp-iii-life-sciences-sec-10-q-report/", "source_name": "TradingView", "published_at": "2025-11-13T08:40:25", "published_display": "13 Nov 2025 08:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Oaktree Acquisition Corp. III Appoints New CFO", "summary": "Oaktree Acquisition Corp. III Life Sciences Class A (OACC) has appointed George A. Martinez as its new Chief Financial Officer, succeeding Thomas Sweeney who resigned on October 29, 2025. Martinez, a Senior Vice President at Oaktree Capital Management and a Certified Public Accou", "url": "https://www.theglobeandmail.com/investing/markets/stocks/OACC/pressreleases/35809691/oaktree-acquisition-corp-iii-appoints-new-cfo/", "source_name": "The Globe and Mail", "published_at": "2025-10-30T10:10:07", "published_display": "30 Oct 2025 10:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Oaktree Acquisition Corp. III Life Sciences appoints David A. Berry as director By Investing.com - Investing.com Australia", "summary": "Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC) announced the appointment of David A. Berry, MD, PhD, as an independent director. Dr. Berry, co-founder of Averin Capital and former partner at Flagship Pioneering, brings extensive experience from the life sciences sector", "url": "https://m.au.investing.com/news/sec-filings/oaktree-acquisition-corp-iii-life-sciences-appoints-david-a-berry-as-director-93CH-4068354?ampMode=1", "source_name": "Investing.com Australia", "published_at": "2025-10-18T12:04:26", "published_display": "18 Oct 2025 12:04", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Oaktree Acquisition Corp. III Life Sciences appoints David A. Berry as director By Investing.com - Investing.com South Africa", "summary": "This article reports on the appointment of David A. Berry as a director for Oaktree Acquisition Corp. III Life Sciences. The article content itself is unfortunately missing due to an application error on the source website.", "url": "https://za.investing.com/news/sec-filings/oaktree-acquisition-corp-iii-life-sciences-appoints-david-a-berry-as-director-93CH-3927179", "source_name": "Investing.com South Africa", "published_at": "2025-10-18T00:16:11", "published_display": "18 Oct 2025 00:16", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Oaktree Acquisition Corp. III Life Sciences appoints David A. Berry as director - Investing.com", "summary": "Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC) has appointed David A. Berry, MD, PhD, as an independent director, who will also serve on the audit, nominating, and compensation committees. Dr. Berry brings extensive experience from Averin Capital and Flagship Pioneerin", "url": "https://m.investing.com/news/sec-filings/oaktree-acquisition-corp-iii-life-sciences-appoints-david-a-berry-as-director-93CH-4295688?ampMode=1", "source_name": "Investing.com", "published_at": "2025-10-17T21:34:00", "published_display": "17 Oct 2025 21:34", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Oaktree Acquisition Corp. III Life Sciences appoints David A. Berry as director", "summary": "Oaktree Acquisition Corp. III Life Sciences has appointed Dr. David A. Berry as an independent director, who will also serve on the audit, nominating, and compensation committees. Dr. Berry brings extensive experience from Averin Capital and Flagship Pioneering, along with his me", "url": "https://www.investing.com/news/sec-filings/oaktree-acquisition-corp-iii-life-sciences-appoints-david-a-berry-as-director-4295688", "source_name": "Investing.com", "published_at": "2025-10-17T17:34:00", "published_display": "17 Oct 2025 17:34", "sentiment": "positive", "sentiment_pct": 71, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Oaktree Acquisition III (OACC) Stock Price, News & Analysis", "summary": "Oaktree Acquisition Corp. III Life Sciences (OACC) is a blank check company operating in the Financial Services sector, with its securities listed on Nasdaq. The article details its business structure, including units, Class A ordinary shares, and redeemable warrants, and highlig", "url": "https://www.stocktitan.net/overview/OACC/", "source_name": "Stock Titan", "published_at": "2025-04-26T05:09:04", "published_display": "26 Apr 2025 05:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Oaktree Acquisition Corp. III Life Sciences (OACC) Stock Price, News & Analysis", "summary": "Oaktree Acquisition Corp. III Life Sciences (OACC) is a SPAC focused on business combinations within the life sciences sector, sponsored by Oaktree Capital Management. As of February 14, 2025, OACC shares are trading at $10.70, up 1.1% since January 1st, 2026. The company is acti", "url": "https://www.marketbeat.com/stocks/NASDAQ/OACC/", "source_name": "MarketBeat", "published_at": "2025-02-14T02:52:03", "published_display": "14 Feb 2025 02:52", "sentiment": "positive", "sentiment_pct": 65, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "The Roundup: Top Takeaways from Oaktree\u2019s Quarterly Letters - December 2023 Edition", "summary": "Oaktree Capital Management's December 2023 \"Roundup\" synthesizes insights from its experts on the 2023 credit markets and future opportunities. Key takeaways include Howard Marks's perspective on interest rates and inflation, suggesting a \"new normal\" for investment strategies. O", "url": "https://www.oaktreecapital.com/insights/insight-commentary/market-commentary/the-roundup-top-takeaways-from-oaktrees-quarterly-letters-december-2023-edition", "source_name": "Oaktree Capital Management", "published_at": "2023-12-14T13:09:11", "published_display": "14 Dec 2023 13:09", "sentiment": "positive", "sentiment_pct": 72, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OACC.U IPO News - Oaktree Capital's SPAC Oaktree Acquisition III withdraws $225 million IPO", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxOQm9pWWFZckVBU0JVYW9KMWlMR3RMZ3lINDYyalVUM0sxdTQzcVRpMGV0NW5WQ1NyTGFQeEFkcWMxNlRNXzZaR3ZBMGRSUXRkbWo3WDdNZ01zZnZDaU5ScFl5UkEydUVTUDZjb3FEWUxoS0c5Y25STDBXRTd5VkJ0M2IwN3FwMWNQS0VjV3pFQTlsNHYtbkRCLXNFY2lpQUphT3lOcm5sRmR6NkJKWkRQc2dNWW5KZGdBbU9SenNmQV93WEUyUGVWaw?oc=5", "source_name": "renaissancecapital.com", "published_at": "2023-02-06T08:00:00+00:00", "published_display": "06 Feb 2023 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Alex Rodriguez and Jennifer Lopez\u2019s Hims & Hers Investment Pays With Oaktree SPAC", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPNTFMcXRINzYwVDlNVEpNNW9henoxd1NTcUdSRDhrZlVqWVAtREVmTTEyUzkxSFVRWGd5eFJGUjJMYTdKN1RmODN5ZVdMN0ltcWpobFY0VjFxWHVtVjdwX05pT1EzT1dsQVFvTURFX09pLWlwVUJhMFpkZG5GUHFDVUtpMnhURHg4ZUhsd1hPa1pWOWRnRUlINnhNanB0UQ?oc=5", "source_name": "Variety", "published_at": "2021-01-12T08:00:00+00:00", "published_display": "12 Jan 2021 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hers, a Multi-Specialty Telehealth Platform, to Become Publicly-Traded via Merger with Oaktree Acquisition Corp.", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiwJBVV95cUxPY1dUNl9EWnkyT3d1UVZzTHdOZHpOUURGN202U1JhZ1FqTDcwalA1X0xpWGJFckJmUVRmNFBUOWw2SnVEazltaTQxVzVfT04tRGtjeDdVOXZkaWh1cDhiN3NaWHpVeWhaWjBpTFIyVHcwZ3pmVmJPeHd5bFJDbVRsLWxjem13dUdaTlI4QjRLMHFuUWpKUy1LNW51Z2wzN1BMYzZFOVhuSGoybDl4Y3FJZHNIcVZOTWZLeFFPSEhGWExRdmdfUzItMjNHbjB4TjJWNWNzSXhvSWNsZmZVQU1MRTE0WGZ1MmVBVGNXcy04d0hPb3ZETTVzZjdJOXhIb0hzRDJKN1RqbkRQZms?oc=5", "source_name": "HIMS Investor Relations", "published_at": "2020-10-01T07:00:00+00:00", "published_display": "01 Oct 2020 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 96, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Oaktree Acquisition (OAC) Stock Price, News & Analysis $OAC", "summary": "This page provides detailed stock analysis, news, and key financial statistics for Oaktree Acquisition (OAC). It includes real-time data like stock price range, volume, and market capitalization, along with news headlines and information on what other stocks OAC shareholders own.", "url": "https://www.marketbeat.com/stocks/NYSE/OAC/", "source_name": "MarketBeat", "published_at": "2020-09-21T14:09:34", "published_display": "21 Sep 2020 14:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Brookfield Buys Majority Stake in Oaktree Capital for Reported $4.7B", "summary": "Brookfield Asset Management is acquiring a majority stake in Oaktree Capital Management for an estimated $4.7 billion. This strategic move strengthens Brookfield's alternative asset management business and expands its reach, while Oaktree Capital gains access to Brookfield's glob", "url": "https://www.globest.com/2019/03/14/brookfield-buys-majority-stake-in-oaktree-capital-for-reported-4-7b/", "source_name": "Globest", "published_at": "2019-03-14T07:44:00", "published_display": "14 Mar 2019 07:44", "sentiment": "positive", "sentiment_pct": 66, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": [{"title": "US Financial Stocks Positioned for Higher Rates and Faster Earnings Growth", "summary": "", "url": "https://news.google.com/rss/articles/CBMiywFBVV95cUxPSEU5RzNWelhyNGwxbjVfb2hJWXVaSnQtR0FZd1RCWHl0R0ZsNWl0d1RzckRrOUFhOHRVQjJxY2M2V1JVdENkMmdQc1h1dW92OFdwUU9HQkJtbURtLW4tQ0Z2YU05SUU3R0REM2FEdHhxc1prOHdvR2FINzY3eTlydzFGM2owQWdXZXlPaHdZTlNmbGNxVUl4U0FuWWJrdWNVenNOelpNRXZLN0hFcmxuOUpib3pIZXFsVHlqSHRFLWE4RkJfbnBLbkpLMNIB0AFBVV95cUxQa2pQQmdvYzVleWNQNW83ZWNFVUFBSm9WOFh0S3YySk1ubC14VDUwU01KVHpCdHhqUTliV3I1eW9XWUdkTHQwTDV1MUxrczhoSWp0THljWWZjeWdzZEVFMDRjWEo2dll3YlVpbEMyUHk1LWZnU19ZWVFEQUhnbzFfWkRIRVhyZlMwcFVxZHEyVjFlZ2ZPSm1jX2lwWWFhQlBIMmNSZmZhWUVnY1dwX2ZmRkdock5kTk15Ym5TaGowd2xFdXZ6eVVZYXl0eGp1WThp?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-18T07:43:13+00:00", "published_display": "18 Jul 2026 07:43", "sentiment": "positive", "sentiment_pct": 82, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "sector", "tier_label": "Sector context"}]}, "total_fetched": 78, "total_relevant": 32, "sentiment_summary": {"positive": 8, "negative": 6, "neutral": 18, "score": 52, "total": 32, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "deals", "primary_label": "Deals and strategy", "confidence": 92, "events": [{"event": "deals", "label": "Deals and strategy", "weight": 15.95, "count": 29}, {"event": "macro", "label": "Macro sensitivity", "weight": 0.55, "count": 1}, {"event": "general", "label": "Market update", "weight": 0.55, "count": 1}, {"event": "earnings", "label": "Earnings", "weight": 0.3, "count": 1}], "positive_events": 8, "negative_events": 6}, "market_context": {"has_market_context": true, "latest_close": 10.7, "latest_week": "2026-07-17", "one_week_move": 0.1, "four_week_move": 0.5, "twelve_week_move": 0.2, "trend_signal": "1", "trend_label": "Trend active", "trend_tone": "positive", "market_dynamics": 0.331344, "market_dynamics_buy_signal": false, "relative_strength": -9.492392, "fair_value_gap": 2.3, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "positive", "expectation_probability": 56.9818, "reaction_label": "Price digesting", "reaction_tone": "neutral", "market_sentence": "+0.1% over one week, +0.5% over four weeks, trend active, and near fair-value range."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 55, "badges": [], "opportunities": [], "risks": [], "event_label": "Deals and strategy", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "MarketBeat", "count": 11}, {"label": "Stock Titan", "count": 3}, {"label": "dars.gov.et", "count": 2}, {"label": "TradingView", "count": 2}, {"label": "Investing.com", "count": 2}, {"label": "simplywall.st", "count": 1}, {"label": "Newsline", "count": 1}, {"label": "Bez Kabli", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 31}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 1}], "events": [{"label": "Deals and strategy", "count": 29}, {"label": "Earnings", "count": 1}, {"label": "Macro sensitivity", "count": 1}, {"label": "Market update", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "52/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Deals and strategy", "tone": "neutral", "text": "92/100 classification confidence."}, {"label": "Company focus", "value": "31", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend active", "tone": "positive", "text": "+0.1% over one week, +0.5% over four weeks, trend active, and near fair-value range."}, {"label": "Latest direct headline", "value": "Negative", "tone": "negative", "text": "Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC) Sees Large Decline in Short Interest"}], "updated_at": "2026-07-22T02:47:22.801984+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}